Search results
Results from the Go Local Guru Content Network
The MYmta user interface at beta launch. MYmta is a mobile application -based passenger information display system developed by the Metropolitan Transportation Authority (MTA) of New York City. A beta version of the app was launched on July 2, 2018, and as of June 2019 is still undergoing beta testing. While other applications exist which serve ...
Beta blocker. Skeletal formula of propranolol, the first clinically successful beta blocker. Beta blockers, also spelled β-blockers, are a class of medications that are predominantly used to manage abnormal heart rhythms ( arrhythmia ), and to protect the heart from a second heart attack after a first heart attack ( secondary prevention ). [1]
Beta-1 blocker blocks the beta-1 receptor and stops the action mentioned above. (signaling Gs, thus activate cAMP pathway by recruiting adenylyl cyclase, leading to higher cardiac output, renin release and lipolysis) Beta 2 blocker. Beta 2 blockers cease action of beta-2 receptor by blocking the receptor and preventing it from being activated.
The app is still in Beta testing, but will eventually succeed the MYmta app. The new app has schedules and service alerts for subways, buses, Long Island Rail Road and Metro-North Railroad all in ...
MYmta, currently in a beta test phase, is available for download on Google Play and the Apple App Store. Find out what's happening in New York City with free, real-time updates from Patch.
Traffic & Transit Revamped MTA App Now Shows Real-Time Bus Ridership Tracker The updated MYmta app will give riders a chance to know how crowded buses are amid coronavirus, officials said.
Metoprolol is a beta blocker, or an antagonist of the β-adrenergic receptors. It is specifically a selective antagonist of the β 1-adrenergic receptor and has no intrinsic sympathomimetic activity. Metoprolol exerts its effects by blocking the action of certain neurotransmitters, specifically adrenaline and noradrenaline.
Bisoprolol. Bisoprolol, sold under the brand name Zebeta among others, is a beta blocker which is selective for the beta-1 receptor [7] and used for cardiovascular diseases, [7] including tachyarrhythmias, high blood pressure, angina, and heart failure. [7] [8] It is taken by mouth. [7]
Selective beta 1 blockers. Selective beta 1 blockers have been shown to have an array of cardiac common side effects, comprising bradycardia, reduced exercise tolerance, hypotension, atrioventricular block, and heart failure. Regarding non-cardiac side effects, they can cause nausea, headache, fatigue, dry mouth, and dry eyes.
Carvedilol is a nonselective beta blocker and alpha-1 blocker. [5] How it improves outcomes is not entirely clear but may involve dilation of blood vessels. [5] Carvedilol was patented in 1978 and approved for medical use in the United States in 1995.